Stress Echo in viability estimation of patients with ischemic heart disease and low LVEF. Prognostic implications.

Similar documents
Stress Echo in coronary artery disease Stefanos Karagiannis MD PhD Cardiologist Director Echocardiology Dept ATHENS MEDICAL CENTER

Rational use of imaging for viability evaluation

Assessment of Ischemia and Viability

Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ;

Viability Testing Using Dynamic Echocardiography

Old and new insights into viability:perfusion and Perfusion Reserve

CHRONIC CAD DIAGNOSIS

Myocardial viability testing. What we knew and what is new

Radiologic Assessment of Myocardial Viability

Cardiovascular Imaging Stress Echo

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Pearls & Pitfalls in nuclear cardiology

Gated blood pool ventriculography: Is there still a role in myocardial viability?

Qualitative and Quantitative Assessment of Perfusion

I have no financial disclosures

Cronicon CARDIOLOGY. N Laredj*, HM Ali Lahmar and L Hammou. Abstract

Stress echo workshop STRESSORS

Insights into Viability- Function and Contractile Reserve

Typical chest pain with normal ECG

Stable Angina: Indication for revascularization and best medical therapy

MR Assessment of Myocardial Viability

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Form 4: Coronary Evaluation

Imaging and heart failure

Form 4: Coronary Evaluation

DOWNLOAD PDF MYOCARDIAL CONTRAST TWO DIMENSIONAL ECHOCARDIOGRAPHY (DEVELOPMENTS IN CARDIOVASCULAR MEDICINE)

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

3/27/2014. Introduction.

Risk Stratification for CAD for the Primary Care Provider

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Coronary Revascularization in Patients witj Severe LV Dysfunction.: Is the concept of viability still viable?


Coronary interventions

Coronary Revascularization for Severe LV Dysfunction Is s. Is the concept of viability testing still viable?

DECLARATION OF CONFLICT OF INTEREST

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

Summary Protocol ISRCTN / NCT REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6

Mechanisms and role of contrast echocardiography

J. Schwitter, MD, FESC Section of Cardiology

Title: Second-Opinion Stress Tele-Echocardiography for Aged Donor Heart Selection

Maria Angela S. Cruz-Anacleto, MD

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

NUCLEAR CARDIOLOGY UPDATE

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Echo in CAD: Wall Motion Assessment

My Patient Needs a Stress Test

Cardiac Imaging Tests

Assessment Of Myocardial Viability

3D-stress echocardiography Bernard Cosyns, MD, PhD

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

The prevalence of atrial fibrillation (AF) increases

CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O.

Identification of Hibernating Myocardium With Quantitative Intravenous Myocardial Contrast Echocardiography

Severe Left Ventricular Dysfunction: Evolving Revascularization Strategies

Form 4: Coronary Evaluation

D EMOGRAPHIC studies have shown that elderly persons. Long-Term Prediction of Mortality in Elderly Persons by Dobutamine Stress Echocardiography

How to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio

Appropriateness of Stress Echocardiography and Nuclear Stress Thallium/Sesta Mibi Testing Methods

CORONARY ARTERY DISEASES

Invited Experts' Case Presentation and 5-Slides Focus Review

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Form 4: Coronary Evaluation

Management of High-Risk CAD : Surgeons Perspective

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

Case Report. Case Report. Ana Lúcia Martins Arruda, Altamiro Ozório, Eloisa Mattos, José Lázaro de Andrade, Thomas Porter, Wilson Mathias Jr

New Insight about FFR and IVUS MLA

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Correlation Between Regional Wall Motion Abnormalities via 2-Dimensional Echocardiography, and Coronary Angiographic Findings

Intravenous Inotropic Support an Overview

The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Stress Echocardiography in VHD: is myocardial contrac8on a reliable marker for ischemia?

Magnetic Resonance Imaging (MRI) for the Assessment of Myocardial Viability

Current Indications for Cardiac MRI: What You See is What You Get?

Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

Value of Index of Microvascular Resistance (IMR) in Microvascular Integrity

Cardiovascular Images

Acute Myocardial Infarction

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Journal of the American College of Cardiology Vol. 34, No. 4, by the American College of Cardiology ISSN /99/$20.

INTRAVENOUS ADENOSINE MYOCARDIAL PERFUSION STUDY (rest/pharmacologic stress SPECT with gated SPECT wall motion studies at rest and post-stress)

Impact of Nicorandil on Renal Function in Patients With Acute Heart Failure and Pre-Existing Renal Dysfunction

Classical teaching about myocardial. The Sleeping Heart: Hibernating Myocardium. Introduction

PET myocard perfusion & viability Riemer Slart

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Imaging of Coronary Artery Disease: II

A New Method to Rapidly Evaluate LVEF from a Contractility Polar Map. Lebeau et al.

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Myocardial Wall Thickness Predicts Recovery of Contractile Function After Primary Coronary Intervention for Acute Myocardial Infarction

Effect of intravenous atropine on treadmill stress test results in patients with poor exercise capacity or chronotropic incompetence ABSTRACT

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

Evaluation of myocardial ischaemia

Stress Testing:Which Study is Indicated for My Patient?

Transcription:

Stress Echo in viability estimation of patients with ischemic heart disease and low LVEF. Prognostic implications. Stefanos Karagiannis MD PhD Cardiologist Director Echocardiology Dept ATHENS MEDICAL CENTER Conflicts: none

AHA/ACC/ESC Guidelines

Table : Comparison of sensitivities and specificities of different stress imaging modalities in detecting myocardial viability (table). *Concluding results from meta-analyses. Table Viability Estimation DSE-MCE SPECT MRI stress PET (DSCMR) Sensitivity 71 97% 84% 96% 100% Specificity 63 95% 54-69% 86-100% 90% Studies have also shown that MCE and cardiac MRI were comparable in predicting functional recovery Circ Cardiovasc Imaging. 2017 Nov;10(11). 10.1161/CIRCIMAGING.117.006530 Cardiovasc Ultrasound. 2017 Mar 21;15(1):7. doi: 10.1186/s12947-017-0099-2 European Society of Cardiology. Eur Heart J. 2013;34:2949 3003 Task Force on the management of stable coronary artery disease

Contractile reserve, which is improvement of contractile dysfunction during low-dose dobutamine infusion, is the hallmark of viable myocardium Stress echo protocols: Exercise (not for viability) Equipment Semi-supine bycicle ergometer Protocols 25 W x 2 with incremental loading Dobutamine Infusion Pump 5 mcg/kg/min 10-20-30-40 Dipyridamole (not for viability) Syringe 0.84 mg/kg in 6 or 0.84 mg/kg in 10 + atropine (0.25 x 4) up to 1 mg Adenosine (not for viability) Syringe 140 mcg/kg/min in 6 Pacing (not for viability) External Pacing From 100 bpm with increments of 10 beats/min up to target heart rate Cardiovasc Ultrasound. 2017 Mar 21;15(1):7. doi: 10.1186/s12947-017-0099-2

DSE protocol Resting two-dimensional echocardiographic examination from the standard apical and parasternal views. Dobutamine is administered intravenously by infusion pump, starting at: 5 g/kg/min for 3 minutes, followed by 10 g/kg/min for 5 minutes and increasing by 10 g/kg/min every 3 minutes to a maximum of 40 g/kg/min (stage 5), and continued for 6 minutes. (Dobutamine exerts its effect by stimulation of β1, β2, and α1-adrenergic receptors) During the test, a 12-lead ECG is recorded every minute. Blood pressure was measured every 3 minutes.

DSE protocol Stop if a target heart rate (85% of a theoretic maximal heart rate (men: (220 age) x 85%; women: (200 age) x 85%) is achieved. IV beta-blocker is administered (1,0 to 5,0 mg) intravenously according to heart rate response and systolic blood pressure, and after peak stress images are acquired to achieve a recovery phase, defined as heart rate within 10% range of resting heart rate.

Δυναμική μελέτη με έγχυση Δοβουταμίνης (Stress Echo-DSE) Ονοματεπώνυμο: Ηλικία: Ημ/νια: Κλινικές Πληροφορίες: Έκθεση: Μετά λήψη εικόνων σε ηρεμία, έγινε έγχυση δοβουταμίνης με ρυθμό 5, 10, 20, 40 μg/kg/min, handgrip και έγχυση ηχοαντιθετικού μέσου και mg atropine. ΑΠ: ηρεμία (rest): ΑΠ: μέγιστη φόρτιση (peak): ΑΠ: αποκατάσταση (recovery): HR: ηρεμία (rest): HR: μέγιστη φόρτιση (peak): HR: αποκατάσταση (recovery): mmhg mmhg mmhg bpm bpm bpm Στη αρχή της φάσης αποκατάστασης (recovery) έγινε έγχυση ενδοφλεβίως mg μετοπρολόλης. Συνολικό score στην ηρεμία: 17 Συνολικό score στη μέγιστη φόρτιση: 17 Συνολικό score στην αποκατάσταση (recovery): 17 Δείκτης τμηματικής κινητικότητας (WMSI) στην ηρεμία: 1,00 Δείκτης τμηματικής κινητικότητας (WMSI) στη μέγιστη φόρτιση: 1,00 1) Πρόσθιο τοίχωμα (κορυφαία λήψη 2 κοιλοτήτων) (τμήματα 2,7): 2) Πρόσθιο μεσοκοιλιακό (κορυφαία λήψη 3 κοιλοτήτων) (τμήματα 1,6): 3) Οπίσθιο μεσοκοιλιακό (κορυφαία λήψη 4 κοιλοτήτων) (τμήματα 5,10): 4) Πλάγιο τοίχωμα (κορυφαία λήψη 4 κοιλοτήτων) (τμήματα 3,8): 5) Κατώτερο τοίχωμα (κορυφαία λήψη 2 κοιλοτήτων) (τμήματα 4,9): 6) Οπισθιο τοίχωμα (κορυφαία λήψη 3 κοιλοτήτων) (τμήματα 15,16): 7) Κορυφαία τοίχωματα (τμήματα 11,12,13,14) : Παρατηρήσεις: Συμπέρασμα: Δείκτης τμηματικής κινητικότητας (WMSI) στην αποκατάσταση (recovery): 1,00 Κλάσμα εξώθησης στην ηρεμία: % Κλάσμα εξώθησης στην μέγιστη φόρτιση: % Κλάσμα εξώθησης στην αποκατάσταση: %

Myocardial viability is assessed only in severely dysfunctional segments; 4 types of wall motion responses are observed: (1) biphasic pattern: improvement of wall motion at 5, 10, or 20 mg/kg/min dobutamine with worsening (ischemia) at higher dosages (2) worsening (ischemia) (3) sustained improvement (4) no change (scar) Severely dysfunctional segments exhibiting a biphasic, worsening or sustained response are considered viable, whereas segments with unchanged wall motion are considered scarred. A patient is considered to have viable myocardium in the presence of 4-5 viable segments (WMSI>0,25) and as non-viable in the presence of 4 viable segments (50% viable myocytes in a given segment)

Myocardial viability estimation during recovery phase of stress echocardiography after acute beta-blocker administration Stefanos E. Karagiannis, Harm H.H. Feringa, Jeroen J. Bax, et al ( Eur Journal Heart Failure April 2007 Volume 9, Issue 4 Pages 325 436)

B-blocker withdrawal is not necessary before DSE when viability is the clinical information in question. However, a completed protocol with continuous image recording is required to detect the full extent of viability.

In medically treated patients with severe global left ventricular dysfunction early after acute uncomplicated myocardial infarction, the presence of myocardial viability identified as inotropic reserve after low-dose dobutamine is associated with a higher probability of survival. The higher the number of segments showing improvement of function, the better the impact is of myocardial viability on survival. The presence of inducible ischemia in this set of patients is the best predictor of cardiac death.

Karagiannis SE, Feringa HH, Vidakovic R, et al. Value of myocardial viability estimation using dobutamine stress echocardiography in assessing risk preoperatively in patients with left ventricular ejection fraction < 35%. Am J Cardiol. 2007;99:1555 9.

Male 49y smoker, Diabetic AMI>Coro: LM 60%, LAD 100%, LCX 80%, RCA 90% Recommended by interventionist for medication not CABG Viability? Stress Echo> viability Recommendation for CABG

2 months post CABG Hibernation is a more chronic process in which chronic severe diffuse epicardial coronary disease leads to a fall in regional and global systolic function over months, and after revascularization [usually with coronary artery bypass graft surgery (CABG)], the hypokinetic myocardium may take 6 12 months to show optimal recovery

DSE and Perfusion for prognosis 2 months postcabg

Male 59yrs 3 vessel disease Inoperable >CRT-D Stress Echo 1> no viability?? Stress Echo 2>Biphasic = Recommendation for CABG

Thank you